Cantitate/Preț
Produs
Total produse
Vezi coșul
Prostate Cancer Screening: Second Edition de Donna Pauler Ankerst

Prostate Cancer Screening: Second Edition: Current Clinical Urology

Editat de Donna Pauler Ankerst, Catherine M. Tangen, Ian M. Thompson
en Limba Engleză Hardback – 11 feb 2009
More than one in six men will develop prostate cancer in their lifetime. In recent years there has been an explosion of information regarding PSA screening and biomarkers for the disease. In Prostate Cancer Screening, Second Edition, the world’s leading experts on prostate cancer detection update the first edition with the latest findings. The book incorporates a series of thoughtful and cutting-edge works from the world’s experts in prostate cancer screening, ranging from the current status quo of prostate cancer screening across the globe to consensus on optimal utilization of the traditional PSA and DRE tests, to cutting-edge research in new biomarkers, biomeasures, and extended risk algorithms for prostate cancer. An additional chapter covers family-based linkage analysis as well as possible pitfalls in prostate cancer biomarker evaluation studies. Timely and authoritative, Prostate Cancer Screening, Second Edition, is an essential text for urologists, oncologists and family physicians, as well as researchers in the biomarker industry who seek methods to better develop and support markers and measures of prostate cancer.
Citește tot Restrânge

Toate formatele și edițiile

Toate formatele și edițiile Preț Express
Paperback (1) 154500 lei  6-8 săpt.
  Humana Press Inc. – 22 noi 2014 154500 lei  6-8 săpt.
Hardback (1) 129903 lei  38-44 zile
  Humana Press Inc. – 11 feb 2009 129903 lei  38-44 zile

Din seria Current Clinical Urology

  • 5% Penile Cancer
    Preț: 117486 lei
  • 5% Robotic and Laparoscopic Reconstructive Surgery in Children and Adults
    Preț: 106913 lei
  • 5% Advanced Male Urethral and Genital Reconstructive Surgery
    Preț: 164343 lei
  • 5% Imaging and Focal Therapy of Early Prostate Cancer
    Preț: 127269 lei
  • 5% Office Urology: The Clinician's Guide
    Preț: 126389 lei
  • 5% Practical Urological Ultrasound
    Preț: 118098 lei
  • 5% Complications of Female Incontinence and Pelvic Reconstructive Surgery
    Preț: 106088 lei
  • 5% Prostate Cancer Diagnosis: PSA, Biopsy and Beyond
    Preț: 107178 lei
  • 5% Pediatric Urology: A General Urologist's Guide
    Preț: 75516 lei
  • 5% Urological Emergencies: A Practical Approach
    Preț: 71293 lei
  • 5% Management of Prostate Cancer
    Preț: 36492 lei
  • 5% Ureteroscopy: Indications, Instrumentation & Technique
    Preț: 138506 lei
  • 5% Bladder Cancer: Current Diagnosis and Treatment
    Preț: 107142 lei
  • 5% Prostate Biopsy: Indications, Techniques, and Complications
    Preț: 106651 lei
  • 5% Management of Prostate Cancer
    Preț: 76431 lei
  • 5% Male Infertility: Problems and Solutions
    Preț: 69008 lei
  • 5% Advanced Endourology: The Complete Clinical Guide
    Preț: 156435 lei
  • 5% Bladder Dysfunction in the Adult: The Basis for Clinical Management
    Preț: 106636 lei
  • 5% Sexual Function in the Prostate Cancer Patient
    Preț: 96518 lei
  • 5% Urologic Prostheses: The Complete Practical Guide to Devices, Their Implantation, and Patient Follow Up
    Preț: 75164 lei
  • 5% Minimally Invasive Therapy for Urinary Incontinence and Pelvic Organ Prolapse
    Preț: 107093 lei
  • 5% Transition and Lifelong Care in Congenital Urology
    Preț: 69676 lei
  • 5% Urological Men’s Health: A Guide for Urologists and Primary Care Physicians
    Preț: 105859 lei
  • 5% Androgen Deficiency and Testosterone Replacement: Current Controversies and Strategies
    Preț: 105068 lei
  • 5% Female Urology: A Practical Clinical Guide
    Preț: 138279 lei
  • 5% Pediatric Robotic Urology
    Preț: 127230 lei
  • 5% Active Surveillance for Localized Prostate Cancer: A New Paradigm for Clinical Management
    Preț: 145202 lei
  • 5% Urologic Robotic Surgery
    Preț: 127899 lei
  • 5% Oral Pharmacotherapy for Male Sexual Dysfunction: A Guide to Clinical Management
    Preț: 99648 lei
  • 5% Urinary Stone Disease: The Practical Guide to Medical and Surgical Management
    Preț: 140352 lei
  • 5% Essential Urologic Laparoscopy: The Complete Clinical Guide
    Preț: 143516 lei
  • 5% Voiding Dysfunction: Diagnosis and Treatment
    Preț: 69077 lei
  • 5% Bladder Cancer: Diagnosis, Therapeutics, and Management
    Preț: 98888 lei
  • 5% Management of Benign Prostatic Hypertrophy
    Preț: 69587 lei
  • 5% Management of Castration Resistant Prostate Cancer
    Preț: 106878 lei
  • 5% Laparoscopic Urologic Oncology
    Preț: 75287 lei
  • 5% Pediatric Urology
    Preț: 75269 lei
  • 5% Pediatric Urology for the Primary Care Physician
    Preț: 82727 lei
  • 5% Renal Cell Carcinoma: Clinical Management
    Preț: 107883 lei
  • 5% Essential Urology: A Guide to Clinical Practice
    Preț: 137700 lei
  • 5% Atlas of Robotic Urologic Surgery
    Preț: 137100 lei

Preț: 129903 lei

Preț vechi: 136739 lei
-5% Nou

Puncte Express: 1949
Preț estimativ în valută:
24861€ • 26225$ • 20777£

Carte tipărită la comandă

Livrare economică 28 decembrie 24 - 03 ianuarie 25

 Adaugă în coș

Wish list
Gift list
Am citit!
Adaugă în listă
Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9781603272803
ISBN-10: 1603272801
Pagini: 424
Ilustrații: XVI, 397 p.
Dimensiuni: 178 x 254 x 28 mm
Greutate: 0.91 kg
Ediția:2nd ed. 2009
Editura: Humana Press Inc.
Colecția Humana
Seria Current Clinical Urology

Locul publicării:Totowa, NJ, United States

Public țintă

Professional/practitioner

Cuprins

Trends in Prostate Cancer Screening.- Overview of US Prostate Cancer Trends in the Era of PSA Screening.- Trends in Prostate Cancer Screening: Overview of the UK.- Trends in Prostate Cancer Screening: Canada.- Trends in Prostate Cancer Screening – Overview of Europe.- Prostate-Specific Antigen.- Evolution of Prostate-Specific Antigen for Screening.- The Performance Characteristics of Prostate-Specific Antigen for Prostate Cancer Screening.- The Performance of PSA for Predicting Prostate Cancer After a Prior Negative Prostate Biopsy.- Subfractions and Derivatives of Total Prostate-Specific Antigen in the Early Detection of Prostate Cancer.- PSA Velocity at Presentation as a Predictor of Prostate Cancer Aggressiveness.- Risk Assessment for Prostate Cancer.- Nomograms for Prostate Cancer.- Decision Aid Criteria and Artificial Neural Networks for Optimizing Prostate Cancer Risk Prediction.- Development of the Prostate Cancer Prevention Trial Prostate Cancer Risk Calculator.- Integration of Risk Assessment in Prostate Cancer Screening.- Family History of Prostate Cancer During Rapidly Increasing Incidence.- Recent Biomarkers for Prostate Cancer.- PSA Isoforms: [?2]proPSA Significant Adjunct to Free PSA.- PCA3.- Transcriptional Profiling of Prostate Cancer: Biomarker Identification and Clinical Applications.- Biomarkers for Prostate Cancer Detection: Family-Based Linkage Analysis and Case–Control Association Studies.- GSTP1 Hypermethylation for Prostate Cancer Detection.- EPCA and EPCA-2 as Potential Biomarkers for Prostate Cancer Detection.- Design and Methodologic Considerations in Biomarker Studies.- Toward a Robust System for Biomarker Triage and Validation – EDRN Experience.- Statistical Evaluation of Markers and Risk Tools for Prostate Cancer Classification andPrediction.- Pitfalls in Prostate Cancer Biomarker Evaluation Studies.- Building upon Recently Completed and Ongoing Prospective Trials.- Prostate-Specific Antigen and Its Role on the Prostate Cancer Prevention Trial.- The Selenium and Vitamin E Cancer Prevention Trial.- PLCO: A Randomized Controlled Screening Trial for Prostate, Lung, Colorectal, and Ovarian Cancer.- The European Randomized Study of Screening for Prostate Cancer (ERSPC).

Recenzii

From the reviews of the second edition:
"This compilation of 27 chapters written by well known urology experts covers a wide range of topics from trends in PSA screening to PSA isoforms … .This book is most suitable for statisticians, scientists, or clinicians who wish to draw their own conclusions regarding PSA screening and related topics. … This book is a superb resource for anyone interested in PSA screening … . It is also an excellent reference for anyone interested in comparing the various studies and controversies from different healthcare systems … ." (Jack H. Mydlo, Doody’s Review Service, May, 2009)

Textul de pe ultima copertă

More than one in six men will develop prostate cancer in their lifetime. In recent years there has been an explosion of information regarding PSA screening and biomarkers for the disease. In Prostate Cancer Screening, Second Edition, the world’s leading experts on prostate cancer detection update the first edition with the latest findings. The book incorporates a series of thoughtful and cutting-edge works from the world’s experts in prostate cancer screening, ranging from the current status quo of prostate cancer screening across the globe to consensus on optimal utilization of the traditional PSA and DRE tests, to cutting-edge research in new biomarkers, biomeasures, and extended risk algorithms for prostate cancer. An additional chapter covers family-based linkage analysis as well as possible pitfalls in prostate cancer biomarker evaluation studies. Timely and authoritative, Prostate Cancer Screening, Second Edition, is an essential text for urologists, oncologists and family physicians, as well as researchers in the biomarker industry who seek methods to better develop and support markers and measures of prostate cancer.

Caracteristici

Comprehensively reviews every aspect of prostate cancer screening, including the latest discoveries in biomarker research Outlines current screening policies by continent and presents the relative ongoing prospective screening trials around the globe Includes supplementary material: sn.pub/extras